Impact of Setting up an "Endocarditis Team" on the Management of Infective Endocarditis.

Endocarditis Team cardiac surgery guidelines infective endocarditis multidisciplinary management prognosis valve disease

Journal

Open forum infectious diseases
ISSN: 2328-8957
Titre abrégé: Open Forum Infect Dis
Pays: United States
ID NLM: 101637045

Informations de publication

Date de publication:
Sep 2019
Historique:
received: 02 05 2019
accepted: 25 06 2019
entrez: 30 10 2019
pubmed: 30 10 2019
medline: 30 10 2019
Statut: epublish

Résumé

Infective endocarditis (IE) remains a severe disease with a high mortality rate. Therefore, guidelines encourage the setup of a multidisciplinary group in reference centers. The present study evaluated the impact of this "Endocarditis Team" (ET). We conducted a monocentric observational study at Strasbourg University Hospital, Strasbourg, France, between 2012 and 2017. The primary end point was in-hospital mortality. Secondary end points were 6-month and 1-year mortality, surgery rate, time to surgical procedure, duration of effective antibiotic therapy, length of in-hospital stay, and sequelae. We also assessed predictors of in-hospital mortality. We analyzed 391 episodes of IE. In the post-ET period, there was a nonsignificant decrease in in-hospital mortality (20.3% vs 14.7%, respectively; This multidisciplinary approach exerted a positive impact on the management of IE and should be considered in all hospitals managing IE.

Sections du résumé

BACKGROUND BACKGROUND
Infective endocarditis (IE) remains a severe disease with a high mortality rate. Therefore, guidelines encourage the setup of a multidisciplinary group in reference centers. The present study evaluated the impact of this "Endocarditis Team" (ET).
METHODS METHODS
We conducted a monocentric observational study at Strasbourg University Hospital, Strasbourg, France, between 2012 and 2017. The primary end point was in-hospital mortality. Secondary end points were 6-month and 1-year mortality, surgery rate, time to surgical procedure, duration of effective antibiotic therapy, length of in-hospital stay, and sequelae. We also assessed predictors of in-hospital mortality.
RESULTS RESULTS
We analyzed 391 episodes of IE. In the post-ET period, there was a nonsignificant decrease in in-hospital mortality (20.3% vs 14.7%, respectively;
CONCLUSIONS CONCLUSIONS
This multidisciplinary approach exerted a positive impact on the management of IE and should be considered in all hospitals managing IE.

Identifiants

pubmed: 31660397
doi: 10.1093/ofid/ofz308
pii: ofz308
pmc: PMC6735925
doi:

Types de publication

Journal Article

Langues

eng

Pagination

ofz308

Informations de copyright

© The Author(s) 2019. Published by Oxford University Press on behalf of Infectious Diseases Society of America.

Références

Clin Infect Dis. 2015 Mar 1;60(5):741-9
pubmed: 25389255
JAMA. 2018 Jul 3;320(1):72-83
pubmed: 29971402
JAMA. 2016 Feb 23;315(8):801-10
pubmed: 26903338
Circulation. 2013 Jun 11;127(23):2272-84
pubmed: 23648777
Open Heart. 2017 Dec 27;4(2):e000699
pubmed: 29344368
Circulation. 2015 Jan 13;131(2):131-40
pubmed: 25480814
Arch Intern Med. 2009 Jul 27;169(14):1290-8
pubmed: 19636030
PLoS One. 2013 Dec 09;8(12):e82665
pubmed: 24349331
Clin Infect Dis. 2007 Feb 1;44(3):364-72
pubmed: 17205442
Ann Thorac Surg. 2012 Aug;94(2):489-95; discussion 496
pubmed: 22704800
Lancet. 2012 Mar 10;379(9819):965-975
pubmed: 22317840
Arch Intern Med. 2009 Mar 9;169(5):463-73
pubmed: 19273776
Eur Heart J. 2011 Aug;32(16):2027-33
pubmed: 19329497
N Engl J Med. 2012 Jun 28;366(26):2466-73
pubmed: 22738096
Eur Heart J. 2016 Mar 7;37(10):840-8
pubmed: 26685134
Circulation. 2015 Oct 13;132(15):1435-86
pubmed: 26373316
Eur Heart J. 2015 Nov 21;36(44):3075-3128
pubmed: 26320109
Clin Infect Dis. 2012 May;54(9):1230-9
pubmed: 22492317
Eur Heart J. 2011 Aug;32(16):2003-15
pubmed: 19208650
Am J Cardiol. 2013 Oct 15;112(8):1171-6
pubmed: 23831163
Circulation. 2016 Oct 25;134(17):1280-1292
pubmed: 27777297

Auteurs

Yvon Ruch (Y)

Department of Infectious Disease, Strasbourg University Hospital, Strasbourg, France.

Jean-Philippe Mazzucotelli (JP)

Department of Cardiovascular Surgery, Strasbourg University Hospital, Strasbourg, France.

François Lefebvre (F)

Department of Biostatistics, Strasbourg University Hospital, Strasbourg, France.

Aurélie Martin (A)

Department of Infectious Disease, Strasbourg University Hospital, Strasbourg, France.

Nicolas Lefebvre (N)

Department of Infectious Disease, Strasbourg University Hospital, Strasbourg, France.

Nawal Douiri (N)

Department of Infectious Disease, Strasbourg University Hospital, Strasbourg, France.

Philippe Riegel (P)

Laboratory of Bacteriology, Strasbourg University Hospital, Strasbourg, France.

Tam Hoang Minh (T)

Department of Cardiovascular Surgery, Strasbourg University Hospital, Strasbourg, France.

Hélène Petit-Eisenmann (H)

Department of Cardiology, Strasbourg University Hospital, Strasbourg, France.

Yves Hansmann (Y)

Department of Infectious Disease, Strasbourg University Hospital, Strasbourg, France.

Xavier Argemi (X)

Department of Infectious Disease, Strasbourg University Hospital, Strasbourg, France.

Classifications MeSH